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A c c e p t e d M a n u s c r i p t encountered in practice. The number of cases assigned to each practice was proportional to the number of dairy 74 cows in the county where the practice operated and based on the number of participating practices in the county. 75
The objective was to obtain milk samples from 1000 cases distributed geographically in proportion to the 76 number of dairy cows in different regions of the country. 77
78
Only lactating cows with macroscopically altered milk in one or more quarters and with no previous episode of 79 clinical mastitis in the current lactation were sampled. Moreover, the previous routine cow composite milk 80 somatic cell count (CSCC) of the cow should have been <200 000 cells/mL and the cow should not have been 81 treated with antimicrobials in the preceding 30 days. When a case was identified, the responsible veterinarian 82 collected individual milk-samples aseptically from all quarters with macroscopic signs of mastitis. 83
Bacteriological culture 84
Milk samples were cultured at the respective veterinary practice according to their routine procedures, usually 85 employing blood-, mannitol-salt-and McConkey agar plates incubated at 37 0 C for 16-24 h. After evaluation at 86 the practice, plates were sent to the National Veterinary Institute (SVA) irrespective of culture results. Most 87 plates arrived within one week after sampling and mostly within four days (>80%). At SVA, growth on the 88 plates was evaluated and additional laboratory tests performed in accordance with the routines at the Mastitis 89 laboratory. Briefly, Staphylococcus aureus was identified by means of typical colony morphology, α-and β-90 haemolysis and positive coagulase reaction. Staphylococci other than S. aureus were identified by typical colony 91 morphology and negative coagulase reaction but were not determined to species level. Streptococci were typed 92 to species level employing the CAMP reaction and 12 biochemical reactions (hippurate, aesculin, salicine, 93 sorbitol, mannitol, raffinose, lactose, saccharose, inuline, trehalose, starch, and glycerine). For isolates not 94 identified with these methods, Lancefield grouping (Streptex, Murex Biotech limited, Dartford, UK) was used. 95
Gram-negative bacteria with typical colony morphology and positive for p-Nitrophenyl-β-D-96 glucupyranosiduronic acid (PGUA) and indole were considered Escherichia coli. For other Gram-negative 97 bacteria, oxidase reaction and API 20 E or API 20 NE (Bio-Mérieux, France) was used. A milk sample was 98 classified as positive if at least one colony-forming unit (CFU) of S. aureus or S. agalactiae was isolated. For 99 other agents, the presence of at least three CFU was needed for positive classification. Samples were classified as 100 contaminated and excluded from the study if three or more bacterial types were isolated from one milk sample 101 and growth of a major udder pathogen was not identified. 102
A c c e p t e d M a n u s c r i p t 5 dysgalactiae, Streptococcus agalactiae, Escherichia coli and Klebsiella spp. were selected for susceptibility 106 testing. When the same bacterial species was isolated from more than one udder quarter in the same cow, only 107 one isolate was included to avoid a clustering effect. Isolates of different bacterial species from different udder 108 quarters in the same cow, or different species isolated from the same udder quarter, were included however. 109
Susceptibility testing 110
Isolates were tested for antimicrobial susceptibility by determination of minimum inhibitory concentration 111 (MIC) using a microdilution method. Testing was performed according to CLSI (formerly NCCLS) 112 recommendations (NCCLS, 2002) using VetMIC™ panels (National Veterinary Institute, Uppsala, Sweden) and 113 cation adjusted Mueller-Hinton broth (Becton Dickinson, Cockeysville, USA). Antimicrobials and range of 114 concentrations tested are given in Tables 1-3 . For testing of oxacillin susceptibility in staphylococci, 2% NaCl 115 was added to the broth. Quality control strains, S. aureus ATCC 29213, S. aureus ATCC 25923 and E. coli 116 ATCC 25922, tested in parallel with each batch of isolates, were on all occasions within acceptable ranges. All 117 isolates of staphylococci were in addition examined for β-lactamase production by the "clover-leaf" method as 118 described by Bryan and Godfrey (1991) . Staphylococci with MIC for oxacillin >2 mg/L were retested using the 119 same VetMIC panel but at a lower temperature, 30°C. Isolates with MIC >2 mg/L on retesting were examined 120 for presence of the mecA-gene by PCR according to Smyth and others (2001) . 121 122 Isolates were classified as susceptible or resistant based on species-specific epidemiological cut-off values issued 123 by European Committee on Antimicrobial Susceptibility Testing (EUCAST) (http\\www.eucast.org). For 124 staphylococci, the EUCAST cut-off value for clindamycin (>0.25 mg/L) could not be used since it is outside the 125 range of tested concentrations. Moreover, in S. aureus the EUCAST cut-off value for neomycin (>1 mg/L) 126 would have split the distribution of MICs an inappropriate way and a higher value (>2 mg/L) was therefore used. 127
For the same reason, a higher cut-off value (>4 mg/L) for gentamicin than recommended by EUCAST (>2 mg/L) 128 was used in E. coli. Cut off-values used are given in Table 1 This isolate was phenotypically resistant to the β-lactam antimicrobials penicillin and oxacillin and had a high 159 MIC to cephalothin (>1 mg/L). In addition the isolate was resistant to tetracycline and had a high MIC to 160 streptomycin (64 mg/L). The isolate was confirmed as S. epidermidis on typing using the Staph-Zym test 161 (Rosco Diagnostics, Taastrup, Denmark). 162
A c c e p t e d M a n u s c r i p t
The results for streptococci are difficult to evaluate since EUCAST cut-off values are lacking for the species 164 tested. Of the six S. agalactiae isolates, two were resistant to tetracycline ( Table 2) . One of these isolates had 165 high MICs to clindamycin (>8 mg/L), erythromycin (1 mg/L) and spiramycin (>64 mg/L) indicating acquired 166 resistance also to these antimicrobials. For both S. dysgalactiae and S. uberis there are no cut off values for 167 tetracycline but distributions of MICs for this antimicrobial were bimodal indicating acquired resistance in some 168 isolates (Table 2) . One isolate of S. uberis had a deviating high MIC to trimethoprim sulphonamide (2 mg/L). 169
MICs to penicillin were below the epidemiological cut-off values in S. agalactiae and S. dysgalactiae. For S 170 uberis there is no cut-off value for penicillin but seven isolates had deviating high MICs (0.12-0.25 mg/L) ( Table  171 2). 172
173
The results for Klebsiella spp. are also difficult to interpret since cut-off values are lacking. However most 174
isolates were resistant to ampicillin and a few also to tetracycline (7.1%) or sulphonamide (9.5%) ( Table 3) . 175
Bimodal distributions of MICs indicate acquired resistance in some isolates to streptomycin or trimethoprim. 176
177
Among E. coli, 20 isolates (12.3%) were resistant to one or more antimicrobial. Sixteen isolates (9.8%) were 178 resistant to at least two, and 12 (7.4%) to three or more antimicrobials (Table 4 ). The most common traits were 179 resistance to streptomycin (11.0%), sulphonamides (8.6%) or ampicillin (7.4%) ( Table 3) . Ten isolates (6.1%) 180 were resistant to all these antimicrobials. 181
Discussion 182
Udder pathogens were isolated from milk samples collected under strict inclusion criteria by systematic 183 sampling from all parts of Sweden. Data presented should therefore provide a good estimate of antimicrobial 184 susceptibility of udder pathogens encountered in acute clinical mastitis in the field. Susceptibility data was 185 interpreted according to species-specific epidemiological cut-off values separating the wild type population from 186 the subpopulation that has acquired reduced susceptibility, here classified as resistance. To identify acquired 187 reduced susceptibility is most relevant for monitoring purposes and recommended by the European Food Safety 188 Authority (EFSA, 2008) but it should be understood that reduced susceptibility not always implies clinical 189 resistance. Susceptibility data presented as distributions of MICs, as in the present paper, can easily be 190 reevaluated using other cut-off values and is thereby available for other interpretations. 191 A c c e p t e d M a n u s c r i p t studies from 1982 (10.4%) and 1985 (10.0%) (Franklin and Horn af Rantzien, 1983; Robertsson and Franklin, 196 1987) in which β-lactamase production was used to define resistance, as in the present study. In fact similar 197 frequencies (10-13%) were found already in the 1950s, -60s and -70s using disc diffusion (Holmberg, 1975) or 198 agar-cup methods (Wallmark and Thörne, 1958) . Comparisons between studies should be made with caution and 199 in the light of possible differences in methodology and selection of isolates but the prevalence of penicillin 200 resistance among S. aureus seems to have changed very little over the last 25 years. In fact the prevalence in the 201 present study (7.1%) is about the same (6.1%) as among 181 isolates from acute clinical mastitis tested in 1995 202 using the same methodology as in the present study (Nilsson et al., 1997) . In CNS occurrence of penicillin 203 resistance was numerically higher in 1995 (25.7%) than in the present study (12.5%) but the limited number of 204 isolates tested precludes conclusions on trends. aureus is largely influenced by spread of resistant clones as suggested by Aarestrup and Jensen (1998) . Use of 214 penicillin likely imposes a selection pressure by leaving animals with unresolved infections as reservoirs of 215 resistant S. aureus. Resistance arising de novo is probably less important since horizontal transmission of the 216 blaZ gene is an extremely rare event in staphylococci causing mastitis (Olsen et al., 2006) . This agrees with the 217 predominance of a limited number of clones/types of S. aureus within a dairy herd or geographical region 218 (Vintov et al., 2003; Anderson et al., 2006) and the apparent association between resistance phenotype and strain 219 type (Waage et al., 2002; Vintov et al., 2003; Anderson et al., 2006) . 220
A c c e p t e d M a n u s c r i p t mg/L in deviate from the majority of isolates (Guérin-Faublée et al., 2002 , Rossitto et al., 2002 MARAN-2005) . , 1997) . This could be because a higher breakpoint for resistance (>0.5 mg/L) than in the 252 present study was used but probably reflects that enrofloxacin was introduced on the Swedish market in the early 253 1990s, i.e. shortly before the study in 1995. 254
255
Resistance to more than one antimicrobial was rare among staphylococci and streptococci, which is consistent 256 with other studies on isolates from bovine mastitis (Sabour et al., 2004; Anderson et al., 2006) . In contrast, E. 257 coli were often resistant to more than one antimicrobial. Half of the 20 resistant E. coli isolates had streptomycin, 258 sulphonamide and ampicillin resistance in their phenotype and six also tetracycline resistance. All these 259 resistance traits, often in combination, are common in E. coli from the gastrointestinal tract of young cattle in 260 Sweden (SVARM 2003) but rare in E. coli from the gastrointestinal tract of healthy dairy cows (SVARM 2006) . 261
Since ampicillin and tetracycline are rarely used for treatment of mastitis in Sweden, selection of resistant E. coli 262 clones and/or resistance determinants probably occurs outside the udder by use of antimicrobials for treatment of 263 other diseases than mastitis and possibly in other animal categories than adult dairy cows. This is consistent with 264 a high genetic diversity of E. coli associated with mastitis, as reported by Srinivasan et al. (2007) . 265
266

Conclusions 267
This study shows that in Sweden bacteria associated with acute clinical mastitis mostly are susceptible to 268 antimicrobials used in therapy. Most important, the majority of streptococci and staphylococci were sensitive to 269 penicillin, the drug recommended for treatment of mastitis caused by these bacteria. Accordingly, antimicrobial 270 resistance is probably not a major cause for therapeutic failures in treatment of acute clinical mastitis in Swedish 271 dairy cows. However, 7.1% of S. aureus were resistant to penicillin. Therefore, to guide therapy and measures to 272 counteract spread of resistant clones, isolates of this bacterium should be tested for β-lactamase production on a 273 regular basis in herds with udder health problems. 274 M a n u s c r i p t M a n u s c r i p t M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t Table 4 . Resistance phenotypes of Escherichia coli (n=20) resistant to at least one antimicrobial. "R"
indicates resistance.
Number of isolates
Resistance phenotype a Sm Su Am Tc Nal Ef Tm Cm Nm
a Sm: streptomycin; Su: sulphametoxazole; Am: ampicillin; Tc: tetracycline; Nal: nalidixic acid; Ef: enrofloxacin; Tm: trimethoprim; Cm: chloramphenicol; Nm: neomycin.
